Startups
Daiwa unit launches $135m fund to support drug discovery
DCI Partners targets Japan and Taiwan biotech startups developing COVID remedies
DCI Partners targets Japan and Taiwan biotech startups developing COVID remedies
Genetron rides COVID tailwind as health awareness rises and population ages
Chicken grown by US start-up Eat Just meets city-state's standards for use in nuggets
South Korean pharma maker seeks to tap booming overseas demand
Noodle maker Nissin aims to combat food shortages with cultured meat
CEO Naito says trials go 'smoothly' and sees candidate as growth driver
Compatriot CanSino also rushes for mass output as clinical trials continue
Production will fulfill order from British government for 60m doses
Diagnostic kits to help fill US testing gap
South Korean company predicts long-term growth in contract drugmaking business
Tokyo's second deal, after Pfizer agreement, diversifies early-stage supply
Japanese group ties up with US biotech company for late-stage trial
UK company expects to begin Japan tests in August
Singapore tightens rules on travelers from Japan, Hong Kong
Sovereign fund leads UK Glympse Bio's $46.7m fundraising
Relay Therapeutics jumps 75% in Nasdaq debut
Smaller nations join forces to match US-China purchasing power
Drugmaker's two plants can produce 200m doses as candidate moves through trials
80% of Asia300 issues fell in first half of 2020, led by airlines and energy
South Korean drug-making powerhouse sees stock price double this year
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.